Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.57+0.05 (+9.86%)
Close on Nov 13, 2026Market cap $53.35MP/E –Yield –
Citius Oncology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Citius Oncology's price to book ratio was 1.5× on Nov 11, 2026, against 2.6× a year earlier. Over the last 3 years it ranged from 0.9× to 177.4×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −0.4 |
| 2025 | Dec 31, 2025 | 1.9× | −113.4 |
| 2024 | Dec 31, 2024 | 115.3× | +108.3 |
| 2023 | Jan 31, 2023 | 7.0× | +0.0 |
| 2022 | Dec 30, 2022 | 6.9× | – |
See a number that looks wrong?